The MEAL study — another update: data coming soon

In October last year we had expressed the hope that data from the Men’s Eating and Living (MEAL) study would be presented at a major medical meeting this year. … READ MORE …

Let’s prove the obvious all over again

Once again your sitemaster finds himself flabbergasted at just how often we need to repeat similar experiments to prove the obvious. … READ MORE …

Molecular biological reasons for switching to a healthier diet!

Two articles just published this week by a Boston-based research team have implicated Western high-fat diets in risk for metastasis of prostate cancer. … READ MORE …

The MEAL study — an update

Back in 2011, what is now the Alliance for Clinical Trials in Oncology (ACTO) but was then CALGB (Cancer and Leukemia Group B) initiated the Men’s Eating and Living (MEAL) study. This trial is, we hope, going to give us some real answers to a very important question: does diet affect risk for the progression of prostate cancer in men on active surveillance? … READ MORE …

An update from Howard Wolinsky — on active surveillance + type 2 diabetes (and the power of diet)

So regular readers will be aware of several articles by Howard Wolinsky on his experiences as a man monitoring low-risk prostate cancer on active surveillance since 2010. Apparently this was insufficiently challenging. In June he was diagnosed with type 2 diabetes (T2B) as well. … READ MORE …

An update to the PrEvENT trial in England

The Prostate Cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) has been ongoing in England since August 2014 and is an important and serious exploration of how diet and exercise may affect the outcomes of men who are treated for prostate cancer. … READ MORE …

Saturated and unsaturated dietary fats and risk for aggressive prostate cancer

A newly published article in Prostate Cancer and Prostatic Diseases has (potentially) expanded our understanding of the role of saturated fats in men’s diets and consequent risk for diagnosis with aggressive forms of prostate cancer. … READ MORE …